QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 15 February 2005
doi: 10.1242/jcs.01677

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.01677v1 118/5/901    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Santos, C. C. Articles by de A. Lima, A. P. C. Search for Related Content PubMed PubMed Citation Articles by Santos, C. C. Articles by de A. Lima, A. P. C. Social Bookmarking                         What's this?

Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, C.C.S., Ilha do Fundão, Rio de Janeiro, 21949-900 RJ, Brazil

^* Author for correspondence (e-mail: anapaula{at}biof.ufrj.br)

Accepted 8 December 2004

Chagasin is a Trypanosoma cruzi protein that was recently characterized as a tight-binding inhibitor of papain-like cysteine proteases (CPs). Considering that parasite virulence and morphogenesis depend on the endogenous activity of lysosomal CPs of the cruzipain family, we sought to determine whether chagasin and cruzipain interact in the living cell. Ultrastructural studies showed that chagasin and cruzipain both localize to the Golgi complex and reservosomes (lysosome-like organelles), whereas free chagasin was found in small intracellular vesicles, suggesting that chagasin trafficking pathways might intersect with those of cruzipain. Taking advantage of the fact that sodium dodecyl sulphate and ß-mercaptoethanol prevent binding between the isolated proteins but do not dismantle preformed cruzipain-chagasin complexes, we obtained direct evidence that chagasin-cruzipain complexes are indeed formed in epimastigotes. Chagasin transfectants (fourfold increase in CP inhibitory activity) displayed low rates of differentiation (metacyclogenesis) and exhibited increased resistance to a synthetic CP inhibitor. These phenotypic changes were accompanied by a drastic reduction of soluble cruzipain activity and by upregulated secretion of cruzipain-chagasin molecular complexes. Analysis of six T. cruzi strains revealed that expression levels of cruzipain and chagasin are variable, but the molar ratios are fairly stable (50:1) in most strains, with the exception of the G strain (5:1), which is poorly infective. On the same vein, we found that trypomastigotes overexpressing chagasin are less infective than wild-type parasites in vitro. The deficiency of chagasin overexpressers is caused by lower activity of membrane-associated CPs, because membranes recovered from wild-type trypomastigotes restored infectivity and this effect was nullified by the CP inhibitor E-64. In summary, our studies suggest that chagasin regulates the endogenous activity of CP, thus indirectly modulating proteolytic functions that are essential for parasite differentiation and invasion of mammalian cells.

Key words: Trypanosome, Cysteine protease, Chagasin, Inhibitor, Infectivity

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				V. C. Coimbra, D. Yamamoto, K. G. Khusal, V. D. Atayde, M. C. Fernandes, R. A. Mortara, N. Yoshida, M. J. M. Alves, and M. Rabinovitch Enucleated L929 Cells Support Invasion, Differentiation, and Multiplication of Trypanosoma cruzi Parasites Infect. Immun., August 1, 2007; 75(8): 3700 - 3706. [Abstract] [Full Text] [PDF]

				B. O. Smith, N. C. Picken, G. D. Westrop, K. Bromek, J. C. Mottram, and G. H. Coombs The Structure of Leishmania mexicana ICP Provides Evidence for Convergent Evolution of Cysteine Peptidase Inhibitors J. Biol. Chem., March 3, 2006; 281(9): 5821 - 5828. [Abstract] [Full Text] [PDF]

				A. C. Ivens, C. S. Peacock, E. A. Worthey, L. Murphy, G. Aggarwal, M. Berriman, E. Sisk, M.-A. Rajandream, E. Adlem, R. Aert, et al. The Genome of the Kinetoplastid Parasite, Leishmania major Science, July 15, 2005; 309(5733): 436 - 442. [Abstract] [Full Text] [PDF]